Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
1.280
-0.070 (-5.19%)
Oct 8, 2025, 4:00 PM EDT - Market closed

Oncolytics Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
128701009676103
Upgrade
Market Cap Growth
83.36%-29.42%3.71%25.79%-25.81%-17.82%
Upgrade
Enterprise Value
1185771733983
Upgrade
Last Close Price
1.280.911.351.631.392.38
Upgrade
PB Ratio
27.9316.944.784.912.685.31
Upgrade
P/TBV Ratio
28.7716.944.784.912.685.31
Upgrade
Debt / Equity Ratio
0.150.180.020.010.020.02
Upgrade
Quick Ratio
2.242.398.248.1515.3711.56
Upgrade
Current Ratio
2.882.829.019.0516.6912.45
Upgrade
Return on Equity (ROE)
-249.28%-189.05%-102.66%-79.34%-86.45%-182.63%
Upgrade
Return on Assets (ROA)
-74.56%-74.11%-55.46%-40.44%-40.88%-58.93%
Upgrade
Return on Capital (ROIC)
-146.95%-124.82%-76.99%-52.89%-52.97%-124.54%
Upgrade
Earnings Yield
-17.36%-31.29%-21.06%-19.07%-27.18%-17.13%
Upgrade
FCF Yield
-13.77%-26.85%-21.59%-17.98%-23.47%-16.82%
Upgrade
Buyback Yield / Dilution
-11.95%-13.10%-16.53%-8.44%-32.66%-82.22%
Upgrade
Updated Aug 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q